These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7526100)

  • 21. Characterization of activity of alkaline phosphatase (AAP) in capillary endothelium of normal and psoriatic skin.
    Sterry W; Steigleder GK; Neumann G
    Arch Dermatol Res; 1980; 267(2):131-9. PubMed ID: 7406528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
    Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V
    Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide and vascular disease.
    Loscalzo J
    N Engl J Med; 1995 Jul; 333(4):251-3. PubMed ID: 7540723
    [No Abstract]   [Full Text] [Related]  

  • 24. Nitric oxide and biopterin: a study in Chiaroscuro.
    Nathan C
    J Clin Invest; 1994 May; 93(5):1875-6. PubMed ID: 7514187
    [No Abstract]   [Full Text] [Related]  

  • 25. Contributions of NO synthase and heme oxygenase to cGMP formation by cytokine and hemin treated brain capillary endothelial cells.
    Vigne P; Feolde E; Ladoux A; Duval D; Frelin C
    Biochem Biophys Res Commun; 1995 Sep; 214(1):1-5. PubMed ID: 7545388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types.
    Swierkosz TA; Mitchell JA; Tomlinson A; Botting RM; Warner TD; Vane JR
    Pol J Pharmacol; 1994; 46(6):587-92. PubMed ID: 7542521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
    Giaid A; Saleh D
    N Engl J Med; 1995 Jul; 333(4):214-21. PubMed ID: 7540722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells.
    Patel JM; Block ER
    Am J Respir Cell Mol Biol; 1995 Sep; 13(3):352-9. PubMed ID: 7544597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cells.
    Xiao S; Schmidt RJ; Baylis C
    Acta Physiol Scand; 2000 Jan; 168(1):175-9. PubMed ID: 10691797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of nitric oxide synthase activity in arterioles and venules of rat and human intestine.
    Nichols K; Staines W; Rubin S; Krantis A
    Am J Physiol; 1994 Aug; 267(2 Pt 1):G270-5. PubMed ID: 7521135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin.
    Cotton SA; Herrick AL; Jayson MI; Freemont AJ
    J Pathol; 1999 Oct; 189(2):273-8. PubMed ID: 10547586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide synthase activity in human breast cancer.
    Thomsen LL; Miles DW; Happerfield L; Bobrow LG; Knowles RG; Moncada S
    Br J Cancer; 1995 Jul; 72(1):41-4. PubMed ID: 7541238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From endothelium-derived relaxing factor to L-arginine and nitrogen monoxide].
    Jensen BO; Holmsen H
    Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2531-5. PubMed ID: 1384164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.
    Geller DA; Lowenstein CJ; Shapiro RA; Nussler AK; Di Silvio M; Wang SC; Nakayama DK; Simmons RL; Snyder SH; Billiar TR
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3491-5. PubMed ID: 7682706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle.
    Mitchell JA; Sheng H; Förstermann U; Murad F
    Br J Pharmacol; 1991 Oct; 104(2):289-91. PubMed ID: 1724623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice.
    Buttery LD; Springall DR; Andrade SP; Riveros-Moreno V; Hart I; Piper PJ; Polak JM
    J Pathol; 1993 Dec; 171(4):311-9. PubMed ID: 7512644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase.
    Zembowicz A; Hatchett RJ; Radziszewski W; Gryglewski RJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1112-8. PubMed ID: 7505326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide.
    Ravichandran LV; Johns RA; Rengasamy A
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2216-23. PubMed ID: 7541958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide. No endothelial NO.
    Snyder SH
    Nature; 1995 Sep; 377(6546):196-7. PubMed ID: 7545786
    [No Abstract]   [Full Text] [Related]  

  • 40. Formation of muscle-derived nitric oxide (MDNO) is mediated by an inducible nitric oxide synthase.
    Moritoki H; Takeuchi S; Kondoh W
    Jpn J Pharmacol; 1992; 58 Suppl 2():315P. PubMed ID: 1380575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.